If you're looking to add some quality shares to your investment portfolio, then you might want to look at the ASX 50 shares listed below.
Here's why analysts at Morgans are tipping these ASX 50 shares as ones to buy right now:
CSL Limited (ASX: CSL)
The first ASX 50 share to look at is CSL. This biotherapeutics giant could be a top option for investors looking for exposure to the healthcare sector.
Particularly given the underperformance of the CSL share price over the last 12 months, which Morgans appears to see as an opportunity for investors to buy in at a good price. Its analysts have an add rating and $327.60 price target on its shares.
Morgans explained: "Promisingly, plasma collections continue to improve, although remain slightly below pre-pandemic levels, and while industry wide issues remain (eg Omicron; staffing; increase costs), the worst appears behind us."
"While near term challenges remain, the ongoing recovery in plasma collections, coupled with management's confidence, paints a favourable earnings picture," it adds.
Wesfarmers Ltd (ASX: WES)
Another ASX 50 share that is rated highly by Morgans is Wesfarmers. It is of course the conglomerate behind the Bunnings, Kmart, Officework, and Target businesses, as well as a collection of industrial businesses.
The team at Morgans believes that recent weakness in the Wesfarmers share price has created a buying opportunity for investors. Its analysts currently have an add rating and $58.50 price target on its shares.
It said: "Despite ongoing uncertainty in the operating environment, we think WES is well-placed to benefit when conditions improve and continue to view the stock as a core portfolio holding for long-term investors."
This is due to its "diversified group of retail and industrial brands, solid balance sheet and strong leadership team that will continue delivering value for shareholders."
